The 5,000% price hike that made Martin Shkreli infamous is no longer paying off

Ars Technica » Scientific Method 2018-07-19

Summary:

The company lost more than $1M in first quarter of 2018 amid waning sales of $750 pill.

Link:

https://arstechnica.com/?p=1346141

From feeds:

Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific Method

Tags:

Authors:

Beth Mole

Date tagged:

07/19/2018, 19:17

Date published:

07/19/2018, 19:00